Overview
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Completed
Trial end date:
2006-08-01
2006-08-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This Study will evaluate the safety and efficacy of brimonidine in patients with glaucoma or ocular hypertensionPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AllerganTreatments:
Brimonidine Tartrate
Criteria
Inclusion Criteria:- ocular hypertension or glaucoma in both eyes
- currently treated with brimonidine
- requires IOP-lowering therapy in both eyes
Exclusion Criteria:
- uncontrolled systemic disease
- known allergy or sensitivity to brimonidine